Profilo
Lei Lin is currently a Director at Jiangsu Subo Biomedical Holding Co. Ltd. Prior to this, she was a Director at Shanghai Rightongene Biotechnology Co., Ltd. from 2019 to 2022 and a Member-Supervisory Board at iRay Technology Co., Ltd. from 2017 to 2023.
Posizioni attive di Lei Lin
| Società | Posizione | Inizio |
|---|---|---|
Jiangsu Subo Biomedical Holding Co. Ltd.
Jiangsu Subo Biomedical Holding Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Provides forensic and third-party medical testing services | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Lei Lin
| Società | Posizione | Fine |
|---|---|---|
| IRAY GROUP | Direttore/Membro del Consiglio | 01/11/2023 |
| SHANGHAI RIGHTONGENE BIOTECHNOLOGY CO., LTD. | Direttore/Membro del Consiglio | 29/11/2022 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
iRay Technology Co., Ltd.
iRay Technology Co., Ltd. Medical SpecialtiesHealth Technology Manufactures and supplies X-ray flat panel digital detectors | Health Technology |
Shanghai Rightongene Biotechnology Co., Ltd.
Shanghai Rightongene Biotechnology Co., Ltd. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Jiangsu Subo Biomedical Holding Co. Ltd.
Jiangsu Subo Biomedical Holding Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Provides forensic and third-party medical testing services | Commercial Services |
















